Virax Biolabs VRAX
NASDAQ VRAX
$2.23 -0.08 (-3.65%)
At close: Sep 29, 2026 · 4:00 PM EDT

Virax Biolabs (VRAX) Total Debt (2021 - 2026)

Updated

Virax Biolabs (VRAX) recorded Total Debt of $28,477 in fiscal Q4 2026 (quarter ended Mar 31, 2026), down 12.3% from $32,468 a year earlier.

Analysis

Virax Biolabs (VRAX) Total Debt (2021 - 2026) Analysis & Trends

Starting with fiscal Q4 2021, Virax Biolabs' Total Debt history includes 8 quarters.

  • Annual Total Debt has a five-year compound annual growth rate of 49.9% (FY2021 to FY2026).
  • Across earlier fiscal years, Total Debt came in at $32,468 in FY2025, $146,250 in FY2023 and $3,758 in FY2022 (unchanged).
  • The fiscal Q4 2026 figure is the lowest quarterly Total Debt since fiscal Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn 42.55 Bn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn 32.61 Bn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn 26.56 Bn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn -
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn 28.15 Bn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn 14.94 Bn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 12.62 Bn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn 16.81 Bn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn 598.70 Mn
10 Virax Biolabs 934,336.46 -20.61 Mn - 28,477.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 28,477.00
Sep 30, 2025 195,577.00
Mar 31, 2025 32,468.00
Sep 30, 2024 222,728.00
Mar 31, 2023 146,250.00
Sep 30, 2022 390,000.00
Mar 31, 2022 3,758.00
Mar 31, 2021 3,758.00
API Access

Virax Biolabs Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=VRAX&period=max&api_key=YOUR_API_KEY